TCL Archive J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs. May 2, 2008
TCL Archive Drug Discover Groups Recompetition Approved, But Advisors Scale Back Model Development March 15, 1991
TCL Archive Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement October 28, 2011